ABSTRACT
Idiopathic interstitial pneumonias are diseases of significant importance in the daily practice of radiologists working in thoracic radiology, considering the current developments in treatment approaches and clinical implications. However, in addition to these diseases, there are some that are frequently encountered, while others are quite rare, where radiological findings of interstitial involvement are observed. This article aims to highlight important aspects of the clinical and radiological approach to these lung pathologies.
Keywords: Lung diseases, interstitial, thorax
References
1
Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013; 188: 733-48.
2
Barile M. Pulmonary edema: a pictorial review of imaging manifestations and current understanding of mechanisms of disease. Eur J Radiol Open 2020; 7: 100274.
3
Michel CC, Woodcock TE, Curry FE. Understanding and extending the Starling principle. Acta Anaesthesiol Scand 2020; 64: 1032-7.
4
Tsuchiya N, Griffin L, Yabuuchi H, Kawanami S, Shinzato J, Murayama S. Imaging findings of pulmonary edema: part 1. Cardiogenic pulmonary edema and acute respiratory distress syndrome. Acta Radiol 2020; 61: 184-94.
5
Chiu L, Jairam MP, Chow R, Chiu N, Shen M, Alhassan A, et al. Meta-analysis of point-of-care lung ultrasonography versus chest radiography in adults with symptoms of acute decompensated heart failure. Am J Cardiol 2022; 174: 89-95.
6
Han S, Mallampalli RK. The acute respiratory distress syndrome: from mechanism to translation. J Immunol 2015; 194: 855-60.
7
Komiya K, Akaba T, Kozaki Y, Kadota JI, Rubin BK. A systematic review of diagnostic methods to differentiate acute lung injury/acute respiratory distress syndrome from cardiogenic pulmonary edema. Crit Care 2017; 21: 228.
8
Tsuchiya N, Griffin L, Yamashiro T, Gibo S, Okane T, Yasutani T, et al. Imaging findings of pulmonary edema: part 2. Infrequent or unusual pulmonary edema with definitive imaging findings. Acta Radiol 2020; 61: 195-203.
9
Frazier AA, Franks TJ, Cooke EO, Mohammed TL, Pugatch RD, Galvin JR. From the archives of the AFIP: pulmonary alveolar proteinosis. Radiographics 2008; 28: 883-99.
10
Trapnell BC, Nakata K, Bonella F, Campo I, Griese M, Hamilton J, et al. Pulmonary alveolar proteinosis. Nat Rev Dis Primers 2019; 5: 16.
11
Jouneau S, Ménard C, Lederlin M. Pulmonary alveolar proteinosis. Respirology 2020; 25: 816-26.
12
Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology 2008; 246: 697-722.
13
Punatar AD, Kusne S, Blair JE, Seville MT, Vikram HR. Opportunistic infections in patients with pulmonary alveolar proteinosis. J Infect 2012; 65: 173-9.
14
Da Nam B, Kim TJ, Chung MP, Chung MJ, Kim TS, Lee KS. CT findings in pulmonary alveolar proteinosis: serial changes and prognostic implications. J Thorac Dis 2018; 10: 5774-83.
15
Bruce DM, Heys SD, Eremin O. Lymphangitis carcinomatosa: a literature review. J R Coll Surg Edinb 1996; 41: 7-13.
16
Klimek M. Pulmonary lymphangitis carcinomatosis: systematic review and meta-analysis of case reports, 1970-2018. Postgrad Med 2019; 131: 309-18.
17
Higo H, Suzaki N, Nagata T, Togami T, Ohara N, Marukawa M. Pulmonary lymphangitic carcinomatosis from gallbladder cancer mimicking diffuse alveolar haemorrhage. Respirol Case Rep 2020; 8: e00540.
18
Munk PL, Müller NL, Miller RR, Ostrow DN. Pulmonary lymphangitic carcinomatosis: CT and pathologic findings. Radiology 1988; 166: 705-9.
19
Jreige M, Dunet V, Letovanec I, Prior JO, Meuli RA, Beigelman-Aubry C, et al. Pulmonary lymphangitic carcinomatosis: diagnostic performance of high-resolution CT and 18F-FDG PET/CT in correlation with clinical pathologic outcome. J Nucl Med 2020; 61: 26-32.
20
Shaw BM, Shaw SD, McCormack FX. Pulmonary alveolar microlithiasis. Semin Respir Crit Care Med 2020; 41: 280-7.
21
Kosciuk P, Meyer C, Wikenheiser-Brokamp KA, McCormack FX. Pulmonary alveolar microlithiasis. Eur Respir Rev 2020; 29: 200024.
22
Enemark A, Jönsson ÅLM, Kronborg-White S, Bendstrup E. Pulmonary alveolar microlithiasis - a review. Yale J Biol Med 2021; 94: 637-44.
23
Ufuk F. Pulmonary Alveolar microlithiasis. Radiology 2021; 298: 567.
24
Erel F, Güngör C, Sarıoğlu N, Aksu GD, Turan G, Demirpolat G. Spontaneous pneumomediastinum and subcutaneous emphysema secondary to pulmonary alveolar microlithiasis. Tuberk Toraks 2021; 69: 416-20.
25
Castellana G, Castellana G, Gentile M, Castellana R, Resta O. Pulmonary alveolar microlithiasis: review of the 1022 cases reported worldwide. Eur Respir Rev 2015; 24: 607-20.
26
Skeoch S, Weatherley N, Swift AJ, Oldroyd A, Johns C, Hayton C, et al. Drug-induced interstitial lung disease: a systematic review. J Clin Med 2018; 7: 356.
27
Johkoh T, Lee KS, Nishino M, Travis WD, Ryu JH, Lee HY, et al. Chest CT diagnosis and clinical management of drug-related pneumonitis in patients receiving molecular targeting agents and immune checkpoint inhibitors: a position paper from the Fleischner Society. Radiology 2021; 298: 550-66.
28
Ufuk F, Bayraktaroğlu S, Rüksan Ütebey A. Drug-induced lung disease: a brief update for radiologists. Diagn Interv Radiol 2023; 29: 80-90.
29
Cheng M, Lin R, Bai N, Zhang Y, Wang H, Guo M, et al. Deep learning for predicting the risk of immune checkpoint inhibitor-related pneumonitis in lung cancer. Clin Radiol 2023; 78: e377-85.
30
Conte P, Ascierto PA, Patelli G, Danesi R, Vanzulli A, Sandomenico F, et al. Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment. ESMO Open 2022; 7: 100404.
31
Distefano G, Fanzone L, Palermo M, Tiralongo F, Cosentino S, Inì C, et al. HRCT patterns of drug-induced interstitial lung diseases: a review. Diagnostics (Basel) 2020; 10: 244.
32
Bledsoe TJ, Nath SK, Decker RH. Radiation pneumonitis. Clin Chest Med 2017; 38: 201-8.
33
Hanania AN, Mainwaring W, Ghebre YT, Hanania NA, Ludwig M. Radiation-induced lung injury: assessment and management. Chest 2019; 156: 150-62.
34
Yan Y, Fu J, Kowalchuk RO, Wright CM, Zhang R, Li X, et al. Exploration of radiation-induced lung injury, from mechanism to treatment: a narrative review. Transl Lung Cancer Res 2022; 11: 307-22.
35
Vogelius IR, Bentzen SM. A literature-based meta-analysis of clinical risk factors for development of radiation induced pneumonitis. Acta Oncol 2012; 51: 975-83.
36
Arroyo-Hernández M, Maldonado F, Lozano-Ruiz F, Muñoz-Montaño W, Nuñez-Baez M, Arrieta O. Radiation-induced lung injury: current evidence. BMC Pulm Med 2021; 21: 9.
37
Benveniste MF, Gomez D, Carter BW, Betancourt Cuellar SL, Shroff GS, Benveniste APA, et al. Recognizing radiation therapy-related complications in the chest. Radiographics 2019; 39: 344-66.
38
Al-Umairi R, Tarique U, Moineddin R, Jimenez-Juan L, Kha LC, Cheung P, et al. CT patterns and serial CT changes in lung cancer patients post stereotactic body radiotherapy (SBRT). Cancer Imaging 2022; 22: 51.
39
Bouros D, Nicholson AC, Polychronopoulos V, du Bois RM. Acute interstitial pneumonia. Eur Respir J 2000; 15: 412-8.
40
Mukhopadhyay S, Parambil JG. Acute interstitial pneumonia (AIP): relationship to Hamman-Rich syndrome, diffuse alveolar damage (DAD), and acute respiratory distress syndrome (ARDS). Semin Respir Crit Care Med 2012; 33: 476-85.
41
Taniguchi H, Kondoh Y. Acute and subacute idiopathic interstitial pneumonias. Respirology 2016; 21: 810-20.
42
Palmucci S, Roccasalva F, Puglisi S, Torrisi SE, Vindigni V, Mauro LA, et al. Clinical and radiological features of idiopathic interstitial pneumonias (IIPs): a pictorial review. Insights Imaging 2014; 5: 347-64.
43
Criado E, Sánchez M, Ramírez J, Arguis P, de Caralt TM, Perea RJ, et al. Pulmonary sarcoidosis: typical and atypical manifestations at high-resolution CT with pathologic correlation. Radiographics 2010; 30: 1567-86.
44
Lee GM, Pope K, Meek L, Chung JH, Hobbs SB, Walker CM. Sarcoidosis: a diagnosis of exclusion. AJR Am J Roentgenol 2020; 214: 50-8.
45
Scadding JG. Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years’ observation. Br Med J 1961; 2: 1165-72.
46
Zhang Y, Du SS, Zhao MM, Li QH, Zhou Y, Song JC, et al. Chest high-resolution computed tomography can make higher accurate stages for thoracic sarcoidosis than X-ray. BMC Pulm Med 2022; 22: 146.
47
Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160: 736-55.
48
Honda O, Johkoh T, Ichikado K, Yoshida S, Mihara N, Higashi M, et al. Comparison of high resolution CT findings of sarcoidosis, lymphoma, and lymphangitic carcinoma: is there any difference of involved interstitium? J Comput Assist Tomogr 1999; 23: 374-9.
49
Nakatsu M, Hatabu H, Morikawa K, Uematsu H, Ohno Y, Nishimura K, et al. Large coalescent parenchymal nodules in pulmonary sarcoidosis: “sarcoid galaxy” sign. AJR Am J Roentgenol 2002; 178: 1389-93.
50
Koide T, Saraya T, Tsukahara Y, Bonella F, Börner E, Ishida M, et al. Clinical significance of the “galaxy sign” in patients with pulmonary sarcoidosis in a Japanese single-center cohort. Sarcoidosis Vasc Diffuse Lung Dis 2016; 33: 247-52.
51
Susam S, Ucsular FD, Yalniz E, Cinkooglu A, Polat G, Komurcuoglu BE, et al. Comparison of typical and atypical computed tomography patterns regarding reversibility and fibrosis in pulmonary sarcoidosis. Ann Thorac Med 2021; 16: 118-25.
